Commentary on the ASH ISTH NHF WFH 2021 guidelines on the diagnosis of VWD: Reflections based on recent contemporary test data

Emmanuel J. Favaloro

doi:10.1182/bloodadvances.2021005946

Commentary on the ASH ISTH NHF WFH 2021 guidelines on the diagnosis of VWD: Reflections based on recent contemporary test data

Emmanuel J. Favaloro

Nursing, Paramedicine and Healthcare Sciences

Westmead Hospital

Research output: Contribution to journal › Letter › peer-review

10 Citations (Scopus)

26 Downloads (Pure)

Original language	English
Pages (from-to)	416-419
Number of pages	4
Journal	Blood Advances
Volume	6
Issue number	2
Early online date	21 Nov 2021
DOIs	https://doi.org/10.1182/bloodadvances.2021005946
Publication status	Published - 17 Jan 2022

Access to Document

10.1182/bloodadvances.2021005946

204328624 Published articleFinal published version, 734 KBLicence: CC BY-NC-ND

Cite this

@article{63a6099f82c1489eba2c2ed8693c7f0a,

title = "Commentary on the ASH ISTH NHF WFH 2021 guidelines on the diagnosis of VWD: Reflections based on recent contemporary test data",

author = "Favaloro, {Emmanuel J.}",

note = "Funding Information: The author thanks staff members and laboratory participants of Royal College of Pathologists Quality Assurance Program (RCPAQAP) Haematology, as well as past and present members of the Westmead ICPMR laboratory. The opinions expressed in this article are those of the author and not necessarily those of NSW Health Pathology or the RCPAQAP.",

year = "2022",

month = jan,

day = "17",

doi = "10.1182/bloodadvances.2021005946",

language = "English",

volume = "6",

pages = "416--419",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "Elsevier BV",

number = "2",

}

TY - JOUR

T1 - Commentary on the ASH ISTH NHF WFH 2021 guidelines on the diagnosis of VWD

T2 - Reflections based on recent contemporary test data

AU - Favaloro, Emmanuel J.

N1 - Funding Information: The author thanks staff members and laboratory participants of Royal College of Pathologists Quality Assurance Program (RCPAQAP) Haematology, as well as past and present members of the Westmead ICPMR laboratory. The opinions expressed in this article are those of the author and not necessarily those of NSW Health Pathology or the RCPAQAP.

PY - 2022/1/17

Y1 - 2022/1/17

UR - http://www.scopus.com/inward/record.url?scp=85123887122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123887122&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2021005946

DO - 10.1182/bloodadvances.2021005946

M3 - Letter

C2 - 34724706

AN - SCOPUS:85123887122

SN - 2473-9529

VL - 6

SP - 416

EP - 419

JO - Blood Advances

JF - Blood Advances

IS - 2

ER -

Commentary on the ASH ISTH NHF WFH 2021 guidelines on the diagnosis of VWD: Reflections based on recent contemporary test data

Access to Document

Other files and links

Cite this